Active — Not RecruitingNot Applicable

MiDura-Study (Neuro-Patch in Duraplasty)

France, Germany328 participantsStarted 2020-02-06

Plain-language summary

The aim of this study is to collect systematically and proactively data regarding the performance of Neuro-Patch, like complications and handling, under daily clinical practice when used as intended by the manufacturer

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Written informed consent * Age \> 18 years * Duraplasty using Neuro-Patch® according to the Instructions for Use Exclusion Criteria: * Use in infected regions * Use in open cerebrocranial traumata * Use in open spina bifida * Known hypersensitivity to implant materials * Pregnancy * Representation by a legal guardian or under involuntary commitment

What they're measuring

Incidence of complications

Timeframe: until follow-up (up to one year after surgery)

Trial details

NCT IDNCT04189172

SponsorAesculap AG

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-01-27

View on ClinicalTrials.gov More Meningioma trials